OxyContin manufacturer says it has suspended active marketing of the drug in Canada
Purdue Pharma Canada says in a letter to the federal health minister that it wants to help address the opioid crisis but the company denies any wrongdoing in the way it promoted OxyContin in Canada.
Aucun commentaire:
Enregistrer un commentaire